REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/04/2025
Back to search
Official data from USPTO
FRENOVA RENAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
10/05/2025
Trademark type
Combined
Nice classes
42
Filing date
01/21/2016
Registration date
10/04/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/14/2023
Last transaction
10/05/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
03/31/2014
First use in commerce
03/31/2014
Drawing code
3
Owner type
03
Owner location
Waltham, MA
Examiner
SMITH,BRIDGETT G
Law office
M60
Current location
TMO LAW OFFICE 115
Mark description
The mark consists of the following: the stylized words "FRENOVA RENAL RESEARCH" where the "O" in "FRENOVA" is formed from 3 arc shaped segments depicted in the colors light blue, dark blue, and green. The remainder of the wording is depicted in the color black. The white areas in the mark are not claimed as a feature of the mark, and are intended to show background or transparent areas only.
Holders and representatives
Holders
Fresenius Medical Care Holdings, Inc.
Representatives
Fresenius Medical Care Holdings, Inc.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
research servicesconducting clinical research studies in the field of nephrology
Publications
History of USPTO decisions and trademark events.
27 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/14/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/14/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/14/2023
E815
TEAS SECTION 8 & 15 RECEIVED
10/04/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/04/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/22/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/02/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
10/04/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/19/2016
PUBO
PUBLISHED FOR OPPOSITION
07/19/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/29/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/10/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/01/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
05/18/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/18/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
05/18/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/18/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
05/17/2016
ALIE
ASSIGNED TO LIE
05/16/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/16/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
05/16/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/16/2016
DOCK
ASSIGNED TO EXAMINER
05/06/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/28/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/27/2016
NWAP
NEW APPLICATION ENTERED
01/25/2016
Continuous trademark protection
Get notified about every new filing that threatens FRENOVA RENAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.